fibrinogen has been researched along with Lymphoma, Follicular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Arai, N; Baba, Y; Fujiwara, S; Harada, H; Hattori, N; Kabasawa, N; Kawaguchi, Y; Matsui, T; Murai, S; Nakamaki, T; Nakata, A; Saito, B; Sasaki, Y; Shimada, S; Tsukamoto, H; Uto, Y; Watanuki, M; Yanagisawa, K | 1 |
1 other study(ies) available for fibrinogen and Lymphoma, Follicular
| Article | Year |
|---|---|
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Humans; Lymphoma, Follicular; Male; Middle Aged; Prognosis; Retrospective Studies; Rituximab | 2020 |